Trademark: A 2272466
Word
A
Device Descrption:
NUTCRACKER,STYLISED WITH MOLECULAR-DIAGRAM IS LTR A
ID
2272466
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
08 October 2021
Registration Date
08 October 2021
Renewal Date
08 October 2031
Owner(s)
Service
Goods and Services:
Class 1:
Active chemical ingredients, including m-RNA, for use in the manufacture of anti-cancer drugs; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with transcription and translation of nucleic acid; chemical solutions and preparations consisting of pre-mixed reactants and reagents used to transfect nucleic acid into cells in the field of scientific research; active chemical ingredients for use in manufacture of anti-cancer drugs; protein arrays and nucleotide arrays for scientific use; nucleic acids, proteins and peptides for laboratory use; diagnostic preparations for scientific or research use other than for medical purposes.
Active chemical ingredients, including m-RNA, for use in the manufacture of anti-cancer drugs; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with transcription and translation of nucleic acid; chemical solutions and preparations consisting of pre-mixed reactants and reagents used to transfect nucleic acid into cells in the field of scientific research; active chemical ingredients for use in manufacture of anti-cancer drugs; protein arrays and nucleotide arrays for scientific use; nucleic acids, proteins and peptides for laboratory use; diagnostic preparations for scientific or research use other than for medical purposes.
Class 42:
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic sciences; dna analysis services for scientific research purposes; medical and scientific research, in particular in the fields of prevention and treatment cancer; providing scientific research information, consultancy, and advisory services, in particular in the fields of prevention and treatment of cancer treatment; conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; and consulting services for others in the field of design, planning, and implementation of clinical trials; design, engineering, research, development and testing services in the field of nucleic acid sciences for medical, scientific and technological applications; scientific research; scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics.
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic sciences; dna analysis services for scientific research purposes; medical and scientific research, in particular in the fields of prevention and treatment cancer; providing scientific research information, consultancy, and advisory services, in particular in the fields of prevention and treatment of cancer treatment; conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; and consulting services for others in the field of design, planning, and implementation of clinical trials; design, engineering, research, development and testing services in the field of nucleic acid sciences for medical, scientific and technological applications; scientific research; scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics.